LİTERATÜR
[1] Afzelius, H.; Thulin, H.
"Allergic reactions to benzalkonium chloride"
Contact Dermatitis 1979; 5, 1: 60

[2] Balazs, E. A.
"Physical chemistry of hyaluronic acid"
Fed Proc 1958; 17: 1086

[3] Balazs, E. A.; Deulinger, J. L.
"Viscosupplementation: a new concept in the treatment of osteoarthritis"
J Rheumatol 1993; 20 (Suppl. 39): 3

[4] Balazs, E. A.; Freeman, M. I.; Klöti, R.; Meyer-Schwickerath, O.; Regnault, F.; Sweeney, D. H.
"Hyaluronic acid and replacement of vitreous and aqueous humor"
Mod Probl Ophthalmol 1972; 10: 3

[5] Bernatchez, S. F.; Camber, O.; Tabatabay, C.; Gurny, R.
"Use of hyaluronic acid in ocular therapy"
in: Edman, P. (ed.)
"Biopharmaceutics of ocular drug delivery"
CRC Press, Boca Raton Ann Arbor London Tokyo 1993

[6] Brewitt, H.; Honegger, H.; Konitz, H.
"Rasterelektronenmikroskopische Untersuchungen über die Austrocknung des Hornhautepithels und die Wirkung von Tränenersatzflüssigkeiten"
Klein Mbl Augenheilkd 1979; 175: 521

[7] Bron, A. J.
"Prospects for the dry eye"
Trans Ophthalmol Soc UK 1985; 104: 801

[8] Chapman, J. M.; Cheeks, L.; Green, K.
"Interactions of benzalkonium chloride with soft and hard contact lenses"
Arch Ophthalmol 1990; 108: 244

[9] Chung, J.-H.; Fagerholm, P.; Lindström, B.
"Hyaluronate in healing of corneal alkali wounds in the rabbit"
Exp Eye Res 1989; 48: 569

[10] DeLuise, W. P.; Petersen, W. S.
"The use of topical Healon® tears in the management of refractory dry-eye syndrome"
Ann Ophthalmol 1984; 16, 9: 823

[11] Diestelhorst, M.
"Nutzen und Risiken von Konservierungsstoffen in wäßrigen Augentropfen"
Z Prakt Augenheilkd 1990; 11, 4: 230

[12] Engström-Laurent, A.; Laurent, U. B. G.; Lilja, K.; Laurent, T. C.
"Concentration of sodium hyaluronate in serum"
Scand J Clin Lab Invest 1985; 45: 497

[13] Fisher, A. A.; Stillman, M. A.
"Allergic contact sensitivity to Benzalkonium Chloride"
Arch Derm 1972; 106: 169

[14] Fitzsimmons, T. D.; Fagerholm, P.; Harfstrand, A.; Schenholmt, M.
"Hyaluronic acid in the rabbit cornea after excimer laser superficial keratectomy"
Invest Ophthalmol Vis Sci 1992; 33: 3011

[15] Fitzsimmons, T. D.; Molander, N.; Stenevi, U.; Fagerholm, P.; Schengolm, M.; Van Malmborg, A.
"Endogenous hyaluronan in corneal disease"
Invest Ophthalmol Vis Sci 1994; 35: 2774

[16] Fraser, J. R. E.; Laurent, T. C.; Engström-Laurent, A.; Laurent, U. B. G.
"Elimination of hyaluronic acid from the blood stream in the human." Clin Exp Pharmacol Physiol 1984; 17

[17] Gurny, R.; Ryser, J. E.; Tabatabay, C.; Martenet, M.; Edman, P.; Camber, O.
"Precorneal residence time in humans of sodium hyaluronate as measured by gamma scintigraphy"
Graefe's Arch Clin Exp Ophthalmol 1990; 228, 6: 510

[18] Haddox, J. L.; Pfister, R. R.; Yuille-Bar, D.
"The efficacy of topical citrate after alkali injury is dependent on the period of time it is administered." Invest Ophtalmol Vis Sci 1989; 30: 1062

[19] Hamano, T.; Horimoto, J.; Lee, M.; Komemushi, S.
"Sodium hyaluronate eye drops enhance tear film stability"
Jpn J Ophthalmol 1996; 40: 62

[20] Hazlett, L. D.; Barrett, R.
"Sodium hyaluronate eye drops. A scanning and transmission electron microscopy study of the corneal surface"
Ophth Res 1997; 19: 277

[21] Hollwich, F.
"Der Einfluß von Konservierungsstoffen in Augenlösungen auf die lokale Verträglichkeit"
Augenspiegel 1989; 35, 1: 42

[22] Horwath, J.; Schmut, O.; Farr, Ch.; Faulborn, J
"Behandlung des trockenen Auges mit Hyaluronat-Augentropfen"
Spektr Augenheilkd 1995; 9/5: 215

[23] Itoi, M.; Kim, O,; Kimura, T. u.a.
"Effect of sodium hyaluronate ophthalmic solution on peripheral staining of rigid contact lens wearers"
CLAO 1995; 21, 4: 261

[24] Kitano, S.; Otori, T.; Masuda, K.
"Effect of 0.3 % sodium hyaluronate ophthalmic solution on severe keratoconjunctival epithelial disorders"
J Eye 1993; 10: 603

[25] Kitano, S.; Otori, T.; Masuda, K.; Komemiushi, S.
"Clinical effect of sodium hyaluronate ophthalmic solution on keratoconjunctival epithelial disorders"
Folia Ophthalmol Jpn 1993; 44: 487

[26] Koniszewski, G.; Bäurle, G.
"Allergisches Kontaktekzem und Conjunctivitis allergica durch Konservierungsmittel"
Z Prakt Augenheilkd 1989; 10: 75

[27] Krieglstein, G. K.
"Konservierungsstoffe in ophthalmologischen Arzneimitteln"
Z Prakt Augenheilkd 1981; 2: 59

[28] Laflamme, M. Y.; Swieca, R.
"A comparative study of two preservative-free tear substitutes in the management of severe dry eye"
Can J Ophthalmol 1988; 23, 4: 174

[29] Laurent, T. C.
"Biochemistry of hyaluronan"
Acta Otolaryngol 1987; 442 (Suppl.): 7

[30] Laurent, U. B. G.
"Hyaluronate in human aqueous humor"
Arch Ophthalmol 1983; 101: 129

[31] Laurent, U. B. G..; Fraser, J. R. E.
"Disappearance of concentrate hyaluronan from the anterior chamber of monkey eyes. "Exp Eye Re 1990; 65

[32] Laurent, U. B. G.; Dahl, L. B.; Lilja, K.
"Hyaluronan injected in the anterior chamber of the eye is catabolized in the liver"
Exp Eye Res 1993; 57: 435

[33] Limberg, M. B.; McCaa, C.; Kisshing, G. E.; Kaufman, H. E.
"Topical application of hyaluronic acid and chondroitin sulfate in the treatment of dry eyes"
Am J Ophthalmol 1987, 103: 194

[34] Mengher, L. S.; Pandher, K. S.; Bron, A. J. Davey, C. C.
"Effect of sodium hyaluronate (0.1 %) on break-up time (NIBUT) in patients with dry eyes"
Brit J Ophthalmol 1986; 70: 442

[35] Meyer, K.; Palmer, J. W.
"The polysaccharide of the vitreous humor"
J Biol Chem 1934; 107: 629

[36] Miyauchi, S.; Morita, M.; Kuramoto, K.; Horie, K.
"Hyaluronan and chondroitin sulfate in rabbit tears"
Curr Eye Res 1996; 15, 2: 131

[37] Miyauchi, S.; Sugiyama, T.; Machida, A.; Mizumo, S.; Tokuyasu, K.
"The biological half-life of 14C-labeled sodium hyaluronate in tears of rabbit after ophthalmic instillation"
Pharmacometr 1993; 46, 4: 261

[38] Miyauchi, S.; Iwata, S.
"Evaluations on the usefulness of viscous agents in anterior segment surgery. II. Effect on intraocular pressure and clearance from the anterior chamber." J Ocul Pharmacol 1989; 221

[39] Nagata, R.; Nagata, T.; Onimarn, T.; Oneda, S.; Ouishi, M.
"Eye mucosa irritation studies of sodium hyaluronate (SH) in rabbits"
Jpn Pharmacol Ther 1992; 20, 3: 77

[40] Nakamura, M.; Hikida, M.; Nakano, T.
"Concentration and molecular weight dependency of rabbit corneal epithelial wound healing on hyaluronan"
Curr Eye Res 1992; 11, 10: 981

[41] Nakamura, M.; Hikida, M.; Nakano, T.; Ito, S.; Hamano, T.; Kinoshita, S.
"Characterization of water retentive properties of hyaluronan"
Cornea 1993; 12, 5: 433

[42] Nakamura, M.; Wakashima, Y.; Mibu, H.
"Effect of preservative on hyaluronan-stimulated corneal epithelial wound healing of rabbits"
Folia Ophthalmol Jap 1997; 48: 308

[43] Nelson, J. D.; Farris, R. L.
"Sodium hyaluronate and polyvinyl alcohol artificial tear preparations"
Arch Ophthalmol 1988; 106: 484

[44] Nishida, T.; Nakamura, M.; Mishima, H.; Otori, T.
"Hyaluronan stimulates corneal epithelium migration"
Exp Eye Res 1991; 53: 753

[45] Orsoni, J. G.; Chiari, M.; Guazzi, A.; De Carli, M.; Guidolin, D.
"Efficacité de l'acide hyaluronique en collyre dans le traitement de l'oeil sec"
Ophthalmologie 1988; 2: 355

[46] Oya, T.; Obata, H.; Miyata, K.; Tsurn, T.; Miyauchi, S.
"Quantitative analyses of glycosaminoglycans in tear fluids in normal human eyes and eyes with corneal epithelial disorders"
J Jpn Ophthalmol 1995; 9, 3: 302

[47] Pape, L. G.; Balazs, E. A.
"The use of sodium hyaluronate (Healon®) in human anterior segment surgery"
Ophthalmol 1980; 87: 699

[48] Parker, A. V.; Williams, R. N.: Paterson, C. A.
"The effect of sodium citrate on the stimulation of polymorphonuclear leukocytes. " Invest Ophthalmol Vis Sci 1985; 26: 1257

[49] Paterson, C. A.; Williams, R. N.; Parker, A. V.
"Characteristics of polymorphonuclear leukocyte infiltration into the alkali burned eye and the influence of sodium citrate. " Exp Eye Res 1984; 39: 701

[50] Pfister, R. R.; Haddox, J. L.; Dodson, R. W.; Deshazo, W. F.
"Polymorphonuclear leukocytic inhibition by citrate, other metal chelators and trifluoperazine. "Invest Ophthalmol Vis Sci 1984; 25: 955

[51] Pfister, R. R.; Haddox, J. L.; Lank, K. M.
"Citrate or ascorbate / citrate treatment of established corneal ulcers in the alkali-injured rabbit eye. "Invest Ophthalmol Vis Sci 1988; 29: 1110

[52] Pfister, R. R.; Haddox, J. L.; Snyder, T. L.
"Topical citrate inhibits the adherence of neutrophils to postcapillary venules." Cornea 1990; 9: 238

[53] Pfister, R. R.; Nicolaro, M. L.; Paterson, C. A.
"Sodium citrate reduces the indidence of corneal ulcerations and perforations in extreme alkali-burned eyes - asetylcysteine and ascorbate have no favorable effect. " Invest Ophthalmol Vis Sci 1981; 21: 486

[54] Polack, F. M.; McNiece, M. T.
"The treatment of dry eye with Nahyaluronate (Healon®)
Cornea 1982; 1: 133

[55] Radda, T. M.; Stelzer, N.; Gottlob, I.
"Trockenes Auge - Therapie mit hypoosmolaren Natriumhyaluronat-Tropfen"
Spektr Augenheilkd 1989; 3/4: 174

[56] Redaelli, C.; Mazzacane, D.; Zennaro, G.; Zorzoli, G.
"Efficacia del collirio all'acido ialuronico allo 0,1 % nelle cheratocongiuntiviti secche gravi"
Ann Ottalmol Clin Ocul 1987; 113, 1: 45

[57] Reim, M.; Lenz, V.
"Behandlung von schweren Verätzungen mit hochpolymerer Hyaluronsäure (Healon®)"
Fortschr Ophthalmol 1984; 81: 323

[58] Saettone, M. F.; Chetoni, P.; Torracca, M. T.; Burgalassi, S.; Giannaccini, B.
"Evaluation of muco-adhesive properties and in vivo activity of ophthalmic vehicles based on hyaluronic acid"
Int J Pharm 1989; 51: 203

[59] Saric, D.; Reim, M.
"Behandlung von Verätzungen des vorderen Augenabschnittes mit hochpolymerem Na-hyaluronat (Healon®)"
Fortschr Ophthalmol 1984; 81: 588

[60] Shimizu, A.; Yokoi, N.; Nishida, K.; Kinoshita, S.
"Hyaluronic acid and basal tear turnover"
Invest Ophthalmol Vis Sci 1993; 34 (Suppl. 1471)

[61] Stave, J.; Guthoff, R.
"Wie lange bleiben Salben und Gele auf der Hornhaut"
Ophthalmol Nachr 1999; 2: 22

[62] Stuart, J. C.; Linn, J. G.
"Dilute sodium hyaluronate (Healon) in the treatment of ocular surface disorders"
Ann Ophthalmol 1985; 17, 3: 190

[63] Sugiyama, T.; Miyauchi S.; Machida, A.; Miyarzaki, K.; Tokuyasu, K.; Nakazawa, K.
"The effect of sodium hyaluronate on the migration of rabbit corneal epithelium.
II. The effect of topical application"
J Ocular Pharmacol 1991; 7: 53

[64] Taiti, L.; Mencucci, R.; Bardi, L.; Scrivanti, M.; Salvi, G.
"A double-masked crossover comparison of a new artificial tear preparation containing hyaluronic acid (Lo2A) and a reference artificial tear preparation containing hydroxypropyl-methylcellulose in dry-eye syndrome treatment"
Ann Ottalmol Clin Ocul 1993; 119, 1: 33

[65] Thode, C.; Kilp, H.
"Permeabilitätsänderungen des Hornhautepithels durch ophthalmologische Konservierungsmittel"
Fortschr Ophthalmol 1982; 79:125

[66] Ueno, N.; Yamauchi, H.; Iso, T.
"Safety evaluation of sodium hyaluronate (SPH) in rabbits. III. Assessment of ocular irritation after topical application"
Folia Ophthalmol Jpn 1984; 35, 3: 584

[67] Wilson, W. S.; Duncan, J.; Jay, J. L.
"Effect of benzalkonium chloride on the stability of precorneal tear film in rabbit and man"
Arch Ophthalmol 1975; 59: 667

[68] Wysenbeek, Y. S.; Laya, N.; Ben Sira, I.; Ophir, I.; Ben Shaul, Y.
"The effect of sodium hyaluronate on the corneal epithelium. An ultrastructural study"
Invest Ophthalmol Vis Sci 1988; 29: 194

[69] Yokoi, N.; Komuro, A.; Nishida, K.; Kinoshita, S.
"Effectiveness of hyaluronan on corneal epithelial barrier function in dry eye"
Brit J Ophthalmol 1997; 81: 533